10320 Federal Register / Vol. 66, No. 31 / Wednesday, February 14, 2001 / Notices

TIME: 8:30 a.m. to 5:00 p.m.

ADDRESSES: University of Pennsylvania

Law School, 3400 Chestnut Street,

Philadelphia, Pennsylvania.

FOR FURTHER INFORMATION CONTACT: John

K. Rabiej, Chief, Rules Committee

Support Office, Administrative Office of

the United States Courts, Washington,

DC 20544, telephone (202) 502–1820.

Dated: February 8, 2001.

John K. Rabiej,

Chief, Rules Committee Support Office.

[FR Doc. 01–3709 Filed 2–13–01; 8:45 am]

BILLING CODE 2210–55–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to section 1301.33(a) of Title

21 of the Code of Federal Regulations

(CFR), this is notice that on August 23,

2000, and December 5, 2000, Cerilliant

Corporation, 14050 Summit Drive #121,

P.O. Box 201088, Austin, Texas 78708–

0189, made application by letter to the

Drug Enforcement Administration

(DEA) for registration as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Cathinone (1235) ..................................................................................................................................................................................... I

Methcathinone (1237) .............................................................................................................................................................................. I

N-Ethylamphetamine (1475) .................................................................................................................................................................... I

N,N-Dimethylamphetamine (1480) .......................................................................................................................................................... I

Aminorex (1585) ...................................................................................................................................................................................... I

4-Methylaminorex (cis isomer) (1590) ..................................................................................................................................................... I

Gamma hydroxybutyric acid (2010) ........................................................................................................................................................ I

Methaqualone (2565) ............................................................................................................................................................................... I

Alpha-Ethyltryptamine (7249) .................................................................................................................................................................. I

Lysergic acid diethylamide (7315) ........................................................................................................................................................... I

Tetrahydrocannabinols (7370) ................................................................................................................................................................. I

Mescaline (7381) ..................................................................................................................................................................................... I

3,4,5-Trimethoxyamphetamine (7390) ..................................................................................................................................................... I

4-Bromo-2,5-dimethoxyamphetaime (7391) ............................................................................................................................................ I

4-Bromo-2,5-dimethoxyphenethylamine (7392) ...................................................................................................................................... I

4-Methyl-2,5-dimethoxyamphetamine (7395) .......................................................................................................................................... I

2,5-Dimethoxyamphetamine (7396) ........................................................................................................................................................ I

2,5-Dimethoxy-4-ethylamphetamine (7399) ............................................................................................................................................ I

3,4-Methylenedioxyamphetamine (7400) ................................................................................................................................................ I

5-Methoxy-3,4-methylenedioxyamphetamine (7401) .............................................................................................................................. I

N-Hydroxy-3,4-methylenedioxyamphetamine (7402) .............................................................................................................................. I

3,4-Methylenedioxy-N-ethylamphetamine (7404) .................................................................................................................................... I

3,4-Methylenedioxymethamphetamine (7405) ........................................................................................................................................ I

4-Methoxyamphetamine (7411) ............................................................................................................................................................... I

Bufotenine (7433) .................................................................................................................................................................................... I

Diethyltryptamine (7434) .......................................................................................................................................................................... I

Dimethyltryptamine (7435) ....................................................................................................................................................................... I

Psilocybin (7437) ..................................................................................................................................................................................... I

Psilocyn (7438) ........................................................................................................................................................................................ I

Acetyldihydrocodeine (9051) ................................................................................................................................................................... I

Benzylmorphine (9052) ............................................................................................................................................................................ I

Codeine-N-oxide (9053) .......................................................................................................................................................................... I

Dihydromorphine (9145) .......................................................................................................................................................................... I

Heroin (9200) ........................................................................................................................................................................................... I

Morphine-N-oxide (9307) ......................................................................................................................................................................... I

Normorphine (9313) ................................................................................................................................................................................. I

Pholcodine (9314) .................................................................................................................................................................................... I

Acetylmethadol (9601) ............................................................................................................................................................................. I

Allyprodine (9602) .................................................................................................................................................................................... I

Alphacetylmethadol except Levo-Alphacetylmethadol (9603) ................................................................................................................. I

Alphameprodine (9604) ........................................................................................................................................................................... I

Alphamethadol (9605) ............................................................................................................................................................................. I

Betacetylmethadol (9607) ........................................................................................................................................................................ I

Betameprodine (9608) ............................................................................................................................................................................. I

Betamethadol (9609) ............................................................................................................................................................................... I

Betaprodine (9611) .................................................................................................................................................................................. I

Hydromorphinol (9627) ............................................................................................................................................................................ I

Noracymethadol (9633) ........................................................................................................................................................................... I

Norlevorphanol (9634) ............................................................................................................................................................................. I

Normethadone (9635) .............................................................................................................................................................................. I

Trimeperidine (9646) ............................................................................................................................................................................... I

Para-Fluorofentanyl (9812) ...................................................................................................................................................................... I

3-Methylfentanyl (9813) ........................................................................................................................................................................... I

Alpha-methylfentanyl (9814) .................................................................................................................................................................... I

Acetyl-alpha-methylfentanyl (9815) ......................................................................................................................................................... I

Beta-hydroxyfentanyl (9830) .................................................................................................................................................................... I

Beta-hydroxy-3-methylfentanyl (9831) ..................................................................................................................................................... I

Federal Register / Vol. 66, No. 31 / Wednesday, February 14, 2001 / Notices 10321

Drug Schedule

Alpha-Methylthiofentanyl (9832) .............................................................................................................................................................. I

3-Methylthiofentanyl (9833) ..................................................................................................................................................................... I

Thiofentanyl (9835) .................................................................................................................................................................................. I

Amphetamine (1100) ............................................................................................................................................................................... II

Methamphetamine (1105) ........................................................................................................................................................................ II

Phenmetrazine (1631) ............................................................................................................................................................................. II

Methylphenidate (1724) ........................................................................................................................................................................... II

Amobarbital (2125) .................................................................................................................................................................................. II

Pentobarbital (2270) ................................................................................................................................................................................ II

Secobarbital (2315) ................................................................................................................................................................................. II

Glutethimide (2550) ................................................................................................................................................................................. II

Nabilone (7379) ....................................................................................................................................................................................... II

1-Phenylcyclohexylamine (7460) ............................................................................................................................................................. II

Phencyclidine (7471) ............................................................................................................................................................................... II

1-Piperidinocyclohexanecarbonitrile (8603) ............................................................................................................................................. II

Alphaprodine (9010) ................................................................................................................................................................................ II

Cocaine (9041) ........................................................................................................................................................................................ II

Codeine (9050) ........................................................................................................................................................................................ II

Dihydrocodeine (9120) ............................................................................................................................................................................ II

Oxycodone (9143) ................................................................................................................................................................................... II

Hydromorphone (9150) ............................................................................................................................................................................ II

Diphenoxylate (9170) ............................................................................................................................................................................... II

Benzoylecgonine (9180) .......................................................................................................................................................................... II

Ethylmorphine (9190) .............................................................................................................................................................................. II

Hydrocodone (9193) ................................................................................................................................................................................ II

Levomethorphan (9210) .......................................................................................................................................................................... II

Levorphanol (9220) .................................................................................................................................................................................. II

Isomethadone (9226) ............................................................................................................................................................................... II

Meperidine (9230) .................................................................................................................................................................................... II

Methadone (9250) ................................................................................................................................................................................... II

Methadone-intermediate (9254) .............................................................................................................................................................. II

Morphine (9300) ...................................................................................................................................................................................... II

Thebaine (9333) ...................................................................................................................................................................................... II

Levo-alphacetylmethadol (9648) ............................................................................................................................................................. II

Oxymorphone (9652) ............................................................................................................................................................................... II

Noroxymorphone (9668) .......................................................................................................................................................................... II

Alfentanil (9737) ....................................................................................................................................................................................... II

Sufentanil (9740) ..................................................................................................................................................................................... II

Fentanyl (9801) ........................................................................................................................................................................................ II

The firm plans to manufacture small

quantities of the listed controlled

substances to make deuterated and nondeuterated drug reference standards

which will be distributed to analytical

and forensic laboratories for drug testing

programs.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substances

may file comments or objections to the

issuance of the proposed registration.

Any such comments or objections

may be addressed, in quintuplicate, to

the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, DC 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than April 16,

2001.

Dated: January 25, 2001.

Laura M. Nagel,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 01–3752 Filed 2–13–01; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated September 25, 2000,

and published in the Federal Register

on October 3, 2000, (65 FR 59018),

Chattem Chemicals, Inc., 3801 St. Elmo

Avenue, Building 18, Chattanooga,

Tennessee 37409, made application by

letter to the Drug Enforcement

Administration (DEA) to be registered as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

N-Ethylamphetamine (1475) ......... I

Drug Schedule

4-Methoxyamphetamine (7411) .... I

2,5-Dimethoxyamphetamine

(7396) ........................................ I

Difenoxin (9168) ........................... I

Methylphenidate (1724) ................ II

Pentobarbital (2270) ..................... II

Secobarbital (2315) ...................... II

Diphenoxylate (9170) ................... II

Hydrocodone (9193) ..................... II

The firm plans to bulk manufacture

the listed controlled substances to

produce products for distribution to its

customers.

No comments or objections have been

received. DEA has considered the

factors in Title 21, United States Code,

Section 823(a) and determined that the

registration of Chattem Chemicals, Inc.

to manufacture the listed controlled

substances is consistent with the public

interest at this time. DEA has

investigated Chattem Chemicals, Inc. to

ensure that the company’s registration is

consistent with the public interest. This

investigation included inspection and

testing of the company’s physical

security systems, verification of the